🇺🇸 FDA
Patent

US 8557250

Methods for preparing complex multivalent immunogenic conjugates

granted A61KA61K2039/6037A61K2039/62

Quick answer

US patent 8557250 (Methods for preparing complex multivalent immunogenic conjugates) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Oct 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K2039/6037, A61K2039/62, A61K39/116, A61K39/385